新生儿转座元件与印记基因的表观遗传调控受受孕方式影响:辅助生殖技术 versus 无潜在不孕症的自然受孕
前瞻性纳入51例IVF/ICSI(15例常规IVF、36例ICSI)单胎妊娠与48例自然受孕单胎妊娠,检测脐血和胎盘中三个印记位点及四个转座子家族的DNA甲基化与转录。IVF/ICSI组胎盘H19/IGF2、KCNQ1OT1、LINE-1Hs和ERVFRD-1甲基化水平显著低于对照组,脐血中ERVFRD-1和LINE-1 ORF2表达及胎盘中ERVFRD-1表达降低;胎盘ERVFRD-1表达仅在对照组与出生体重和胎盘重量正相关。
要点
- IVF/ICSI组胎盘H19/IGF2、KCNQ1OT1、LINE-1Hs和ERVFRD-1甲基化水平显著低于自然受孕对照组,脐血无差异。
- IVF/ICSI组脐血ERVFRD-1和LINE-1 ORF2表达及胎盘ERVFRD-1表达低于对照组。
- 胎盘ERVFRD-1表达与出生体重和胎盘重量正相关仅见于对照组。
核心结论
- ART后胎盘中部分转座元件和印记基因的DNA甲基化和/或转录发生改变,脐血中部分转座元件的转录亦有改变。
研究设计与样本
- 前瞻性纳入2013年1月至2015年4月51例IVF/ICSI单胎妊娠(15例常规IVF、36例ICSI),与48例自然受孕单胎妊娠比较。
- 采用焦磷酸测序和定量RT-PCR检测脐血和胎盘三个印记位点(H19/IGF2、KCNQ1OT1和SNURF DMRs)及四个转座子家族(LINE-1、ERVFRD、AluYa5和ERVW)的DNA甲基化和转录。
- 所有数据均校正分娩孕龄、新生儿性别、产次和母亲年龄。
主要发现
- IVF/ICSI组胎盘H19/IGF2、KCNQ1OT1、LINE-1Hs和ERVFRD-1的DNA甲基化水平显著低于对照组胎盘,脐血无差异。
- IVF/ICSI组脐血ERVFRD-1和LINE-1 ORF2表达及胎盘ERVFRD-1表达低于对照组。
- 胎盘ERVFRD-1表达与出生体重和胎盘重量正相关,但仅见于对照组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 对照组为1年内受孕的生育力正常夫妇,无法区分ART与不孕症各自的独立作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do assisted reproductive technologies alter DNA methylation and/or transcription of transposable elements and imprinted genes in cord blood and placenta? SUMMARY ANSWER: After ART, DNA methylation and/or transcription changes of some transposable elements and imprinted genes were found in placenta samples while transcription modifications for some transposable elements were also discovered in cord blood. WHAT IS KNOWN ALREADY: Recent studies have confirmed the increased risk of placenta-related adverse pregnancy outcomes and the excess of imprinted disorders with abnormal methylation patterns after ART, which raises the issue of a potential ART-induced epigenetic risk. STUDY DESIGN, SIZE, DURATION: A total of 51 IVF/ICSI (15 conventional and 36 ICSI) singleton pregnancies were prospectively included from January 2013 to April 2015 and compared to 48 spontaneously conceived singleton pregnancies. PARTICIPANTS/MATERIALS, SETTING, METHODS: The DNA methylation and transcription of three imprinted loci (H19/IGF2, KCNQ1OT1 and SNURF DMRs) and four transposon families (LINE-1, ERVFRD, AluYa5 and ERVW) in cord blood and placenta obtained at birth were assessed by pyrosequencing and quantitative RT-PCR, respectively. All data were adjusted for gestational age at delivery, sex of the newborn, parity and maternal age. MAIN RESULTS AND THE ROLE OF CHANCE: DNA methylation levels of H19/IGF2, KCNQ1OT1, LINE-1Hs and ERVFRD-1 were significantly lower in IVF/ICSI placentas than in control placentas, while there was no difference for cord blood. Moreover, the expression of ERVFRD-1 and LINE-1 ORF2 in cord blood and ERVFRD-1 in placenta was lower in the IVF/ICSI group than in controls. The expression of ERVFRD-1 in placenta correlated positively with birth weight and placenta weight, but only in the control group, thus pointing to the potential deregulation of syncytin function after ART. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The control group of fertile couples having conceived within 1 year prevented us from deciphering the distinct roles of ART and infertility. WIDER IMPLICATIONS OF THE FINDINGS: These novel findings of ERVFRD (syncytin-2) expression correlating with birth weight and placenta weight suggest that more research on syncytins and pregnancy-associated diseases could lead to them being used as biomarkers or even as therapeutic targets. The epigenetic modifications in placenta for sequences involved in foetal development raise the question of their potential effects on pregnancy and future life. These results should encourage us to analyse the exact causes and consequences of epigenetic changes and strive to minimize these variations in the interests of epigenetic safety after ART. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by a grant from Besançon and Dijon University Hospitals. The authors have no conflicts of interest to declare.
引用
- Choux C, Binquet C, Carmignac V, et al. The epigenetic control of transposable elements and imprinted genes in newborns is affected by the mode of conception: ART versus spontaneous conception without underlying infertility. Hum Reprod. 2018. PMID: 29237055. doi:10.1093/humrep/dex366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。